What does the NIHR Research Activity League Table mean to you?

Where does your trust feature on the league table? View the league table data

NIHR Clinical Research Network

Jonathan Sheffield

Dr Jonathan Sheffield, Chief Executive Officer, NIHR Clinical Research Network (CRN)

“The increase in the number of clinical research participants last year and the improvements we are seeing in studies delivering to time and target are fantastic achievements that are contributing to better health and care outcomes in this country. Researchers can be more confident of being able to complete their studies, and more patients will benefit from new and better treatments becoming available.

“Overall, 65 per cent of trusts increased their research activity in 2016-17, demonstrating the growing appetite for research within the NHS. We must continue to invest in the opportunities that clinical research presents, by looking at more innovative ways of delivery and making better use of digital advancements in the health and care sector.” 


Matt Cooper

Commercial activity in the NIHR League Table demonstrating that an ‘ounce of performance is worth pounds of promises’ to the life sciences industry

Matt Cooper, Business Development and Marketing Director at the NIHR Clinical Research Network describes the impact of the NIHR Research Activity Table in relation to commercial research activity in trusts across England in his latest blog.

Go to our Key Statistics page to find out more about our performance

Creating a successful research culture in the NHS

Professor Steve Robson, Consultant in Fetal Medicine, Newcastle Upon Tyne Hospitals NHS Foundation Trust and Clinical Director at NIHR CRN North East North Cumbria

Steve talks about how Newcastle Upon Tyne NHS Foundation Trust has embedded research into day-to-day care, and how they have stayed top of the NIHR league table for six years running.

Pharmaceutical Industry

The NIHR Clinical Research Network supports commercial research studies in the NHS. Colleagues from UK pharmaceutical organisations, explain why the NIHR is important to them.

  • Christine Medhurst, Senior Investigator Site Development Lead at Pfizer
  • Adrienne Clarke, Clinical Team Manager at GSK
  • Sarah Mansfield, Head of Clinical Project Management at NovoNordisk UK
  • Charlotte Chapman, Director, Hub Unit Manager Regional Clinical Operations - Northern Europe at Bristol-Myers Squibb
  • Clare Johnson, Therapeutic Area Lead Cardio-Metabolic Team at Novartis

View the key headlines for the league table

Healthcare professionals

Heather Lambert, Consultant Paediatric Nephrologist, Newcastle Upon Tyne Hospitals NHS Foundation Trust

Heather talks about the importance of research in the NHS and her message to patients and members of the public.